Karpus Investment Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Karpus Investment Management’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-53,950	Closed	-$554K	–	319
2023 Q2	$554K	Hold	53,950	–	–	0.02%	262
2023 Q1	$546K	Hold	53,950	–	–	0.02%	297
2022 Q4	$534K	Hold	53,950	–	–	0.02%	337
2022 Q3	$525K	Buy	+53,950	New	+$524K	0.02%	386

Karpus Investment Management's DALS Position: Q3 2023 in Review

Karpus Investment Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 53,950 shares — an estimated $554K sold.

Karpus Investment Management first reported a position in DALS in Q3 2022 and held it in 4 quarters. The position peaked at $554K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Karpus Investment Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Karpus Investment Management sold 53,950 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $554K.
Karpus Investment Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 4 quarters.
Karpus Investment Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $554K in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Karpus Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.